Skip to main content
. 2024 Aug 23;132(8):087007. doi: 10.1289/EHP14339

Figure 4.

Figures 4A, 4B, 4C, and 4E are box and whiskers plots, plotting Tumor necrosis factor lowercase alpha (picograms per milliliter), ranging from 0 to 250 in increments of 50, Monocyte chemoattractant protein-1 (picograms per milliliter), ranging from 0 to 1,600 in increments of 200; Interleukin-6 (picograms per milliliter), ranging from 0 to 400 in increments of 100; and Aortic atherosclerotic percentage, ranging from 0.0 to 3.0 in increments of 0.5 (y-axis) across Female and Male, each including sex effect, per- and polyfluoroalkyl substances, and interaction (x-axis) for vehicle and per- and polyfluoroalkyl substances, respectively. Figure 4D depicts a stained tissue image of the en face aortas of mice in each treatment group, including female vehicle control, female per- and polyfluoroalkyl substances, male vehicle control, and male per- and polyfluoroalkyl substances.

Exposure of Ldlr/ mice to the PFAS mixture for 7 wk and inflammatory and atherosclerotic outcomes. Circulating cytokine protein levels for (A) TNF-α, (B) MCP-1, and (C) IL-6 were measured from plasma collected at euthanasia from mice of each treatment group (n=5). (D) En face aortas were stained with Oil Red O for n=4 mice per treatment group and representative images of stained aortas are shown. (E) The percentage of staining was quantified to determine aortic atherosclerotic percentage. Two-way ANOVA was used to analyze both main effects (i.e., sex, PFAS), as well as the interaction between sex and PFAS (interaction p<0.05). The Holm–Sidak post hoc test was used for multiple comparisons. With past consultation from biostatisticians, a significant interaction term supersedes the main effects and can make their meaning unclear. We therefore have not included the main effects p-values for any result with a significant interaction. Box plots represent the median values with upper and lower quartiles; whiskers extend to the 1st and 99th percentiles. Data are reported in Excel Tables S9 and S10. Note: ANOVA, analysis of variance; IL, interleukin; Ldlr, low density lipoprotein receptor; MCP, monocyte chemoattractant protein; PFAS, per- and polyfluoroalkyl substances; TNF, tumor necrosis factor.